Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Real-world outcomes of avelumab plus axitinib in patients... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Real-world outcomes of avelumab plus axitinib in patients with advanced renal cell carcinoma in Japan: long-term follow-up from the J-DART2 retrospective study
0
Authors
Taigo Kato
15 more
Taigo Kato
•
Junya Furukawa
13 more
•
Hirotsugu Uemura
Published
November 16, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to review
Share your thoughts on this paper...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
International Journal of Clinical Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Urology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1007/s10147-024-02618-9
License
CC-BY
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
International Journal of Clinical Oncology
Topics
Medicine
Cancer Oncology
Internal Medicine
Urology
Pulmonary And Respiratory Medicine
Show all topics
DOI
10.1007/s10147-024-02618-9
License
CC-BY
